T1	AdverseReaction 1964 1982	allergic reactions
T2	AdverseReaction 1987 1998	anaphylaxis
T3	Factor 1999 2002	may
T4	AdverseReaction 2318 2324	cancer
T5	Factor 2309 2313	risk
T6	AdverseReaction 193 211	Allergic reactions
T7	AdverseReaction 300 314	Radiation risk
E1	AdverseReaction:T1 Hypothetical:E3
E2	AdverseReaction:T2 Hypothetical:E3
E3	Factor:T3
E4	AdverseReaction:T4 Hypothetical:E5
E5	Factor:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
A1	CUI E1 C1527304
A2	UMLS-Preferred-Name E1 Allergic Reaction
A3	MEDDRA-PT E1 Hypersensitivity
A4	MEDDRA-PT-ID E1 10020751
A5	LLT E1 Allergic reaction
A6	LLT-ID E1 10001718
A7	CUI E2 C0002792
A8	UMLS-Preferred-Name E2 anaphylaxis
A9	MEDDRA-PT E2 Anaphylactic reaction
A10	MEDDRA-PT-ID E2 10002198
A11	LLT E2 Anaphylaxis
A12	LLT-ID E2 10002218
A13	CUI E4 C0006826
A14	UMLS-Preferred-Name E4 Malignant Neoplasms
A15	MEDDRA-PT E4 Neoplasm malignant
A16	MEDDRA-PT-ID E4 10028997
A17	LLT E4 Cancer
A18	LLT-ID E4 10007050
A19	CUI E6 C1527304
A20	UMLS-Preferred-Name E6 Allergic Reaction
A21	MEDDRA-PT E6 Hypersensitivity
A22	MEDDRA-PT-ID E6 10020751
A23	LLT E6 Allergic reaction
A24	LLT-ID E6 10001718
A25	CUI E7 C4032503
A26	UMLS-Preferred-Name E7 Risk For Radiation Exposure
A27	MEDDRA-PT E7 Exposure to radiation
A28	MEDDRA-PT-ID E7 10073306
